A disintegrin and metalloprotease with thrombospondin domains (ADAMTS) are a member of peptidase and involved in processing of von Willebrand factor as well as cleavage of aggrecan, versican, brevican and neurocan. Among 19 subfamilies of human ADAMTS, ADAMTS-4 is a zinc-binding metalloprotease and is a famous therapeutic target for arthritis. It has been reported that a flavonoid luteolin shows inhibitory activity against ADMATS-4. In this study, we verified that luteolin is a potent inhibitor of ADAMTS-4 and probed the molecular basis of its action. On the basis of a docking study, we proposed a binding model between luteolin and ADAMTS-4 in which 3',4'-dihydroxyl groups in luteolin formed hydrogen bonding with ADMATS-4 and these interactions are important for its inhibitory activity against ADAMTS-4.
Introduction
A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) is a group of metalloproteases that are found in both in mammals and invertebrates.
1,2 The ADAMTS proteases are identified in 1997 and have been related to a number of diverse diseases. Proteases are the enzymes that "cut up" peptides or proteins in the process called proteolysis. 3 This process is a kind of remodeling process and is particularly important for bone density related diseases such as in osteoporosis, disuse of connective tissues, and during cartilage destruction in arthritis. 1, 4, 5 The ADAMTSs are multi-domain enzymes and zinc dependent proteases. Therefore, it is also classified as a family of matrix metalloproteinases (MMPs).
1,2
In humans, all 19 ADAMTS genes are known and have important roles in connective tissue organization, coagulation, inflammation, arthritis, and cell migration.
6,7 Among them, four ADMATSs (ADAMTS-1, ADAMTS-4, ADAMTS-5, and ADAMTS-9) cleave specific amino acid bonds of the core protein of aggrecan which is a major proteoglycan in articular cartilage. 8 Proteolytic degradation of articular cartilage is a key pathological function of arthropathies such as rheumatoid arthritis (RA). ADAMTS-4 (aggrecanase-1) and ADAMTS-5 (aggrecanase-2) play important roles in pathological aggrecanolysis related on arthritis. 4, 8, 9 The proteolytic enzymes that act on aggrecans are called as aggrecanase. ADAMTS-4 is one of the relatively abundant ADAMTS in humans and is overexpressed by synovial cells and chondrocytes in osteoarthritis and RA.
8 Therefore, the role of ADAMTS-4 as an aggrecanase is considered as a therapeutic target for osteoarthritis and rheumatoid arthritis. Recently, it has been reported that a flavonoid, luteolin, shows inhibitory activities against aggrecan degradation mediated by ADAMTS-4 and ADAMTS-5.
10 From this report, it can be concluded that luteolin may play a role as a prototypically modified disease-agent blocking the unwanted aggrecanase activities in arthritic diseases.
10
Flavonoids are popular natural products and widely distributed in plant kingdom. It has a broad range of medicinal properties such as antioxidant, antiviral, antibacterial, and anticancer activities. 11, 12 The common structure of flavonoids and its numbering scheme is represented in Figure 1 (a). Luteolin is classified as a flavone which has a backbone of 2-phenylchromen-4-one (2-phenyl-1-benzopyran-4-one) as shown in Figure 1 (b). It is often found in leaves of plants such as onion and Vitex negundo Linn and the medicinal effects of luteolin on various human diseases are well known.
13,14
In this study, we proposed the binding model between (Figure 1(c) ) which is a less active inhibitor of ADAMTS-4 was determined, too.
Methods
Docking Study. We performed an automated docking study to determine the binding model between luteolin and ADAMTS. On the basis of the x-ray co-complex structure of ADAMTS-4 and its inhibitors (2RJP.pdb), we defined the active site and considered the receptor-inhibitor interactions.
Computations were performed on a Windows platform using CDOCKER, a CHARMm-based molecular dynamics (MD) method for ligand-docking, in Discovery Sudio modeling (Accelrys Inc., San Diego, USA). [15] [16] [17] This algorithm assumes a rigid protein and permits only the ligand to be flexible. Input Site Sphere parameter specifies a sphere around the center of the binding site, where the CDOCKER experiment is to be performed. The center of the sphere is used in the CDOCKER algorithm for initial ligand placement. The MD simulated annealing process is performed using a rigid protein and flexible ligand. The final minimization step is applied to ligand's docking pose. The minimization consists of 50 steps of steepest descent followed by up to 200 steps of conjugated-gradient using an energy tolerance of 0.001 kcal/ mol.
15

Results and Discussion
Analysis of X-ray Structures of ADAMTS-4. The structures of ADAMTS-4 and ADMATS-5 have a common fold comprising an N-terminal metalloprotease domain region and a C-terminal disintegrin-like domain region by four disulfide bonds. 18 The sequence identity between ADAMTS-4 and -5 is about 48% outside the pre-and prodomains.
18
The overall structures of two ADAMTSs are highly homologous and the active sites of two ADAMTSs include a catalytic zinc ion and two calcium ions in metalloprotease domain. The whole structure of ADAMTS-4 with the label of each domain is represented in Figure 2 .
The active sites of ADAMTS-4 and -5 are also highly conserved with the exception of only four residues. These residues cause the size difference between ADMATS-4 and -5 and this difference is the major factor to determine the selectivity of ADAMTS inhibitors.
The active sites of ADAMTS-4 include all five binding pockets, S1-S3, S1' and S2'. The zinc ion located at the center of a cleft between S1'-S2' pockets. 18 These two pockets are important for binding of an inhibitor at the active site of ADAMTS with metal chelating interactions. Therefore, we defined the active site centering at the S1' and S2' pockets and performed docking studies.
Binding Model between Luteolin and ADAMTS-4. According to the recent report, various natural flavonoids could have an inhibitory effect against ADAMTS-4 and ADAMTS-5 to exert anti-inflammatory effects in vitro and in vivo. However, compared to the flavonoids such as zguggulsterone, genistein, piceatannol, resveratrol, and curcumin, luteolin has the highest capacity to block these enzymes. 10 To verify and understand the inhibitory mechanism of luteolin against ADAMTS-4 and -5, interaction models between luteolin and two ADAMTSs have to be determined.
The interaction model of a known inhibitor and ADAMTS-4 is proved by X-ray crystallography as mentioned before.
Based on this structure, we conducted a docking simulation to characterize the interaction model between luteolin and ADMATS-4. It has been reported that the 4-carbonyl oxygen and 5-OH of flavonoid contribute to forming a stable chelating complex with several metal ion. 19 Similarly, 4-carbonyl oxygen in C-ring and 5-OH in A-ring of luteolin participated in chelating with zinc ion which is already chelating with three histidines in ADMATS-4 as shown in Figure 3(a) . Two carboxyl groups (3'-OH and 4'-OH) in Bring of luteolin formed hydrogen bonding interactions with side chain of D328 and backbone amide of M395 of ADAMTS-4, respectively. Luteolin sustained a hydrophobic interaction with several residues; L330 in S2' pocket, and V394, M395 in S1' pocket. According to the docking results, luteolin was well bound to the active site of ADAMTS-4 having close contacts with both important active site S1' and S2'.
In order to evaluate the binding model of luteolin and ADMATS-4, we performed docking simulation between ADAMTS-4 and genistein which is the weaker inhibitor. Genistein which is classified as an isoflavone showed a much weaker inhibitory activity against ADAMTS-4 and -5 than luteolin. 10 If we can explain the difference of binding model between luteolin/genistein and ADMATSs, the model can provide the insight to understand the action of mechanism of luteolin against ADAMTSs. 4-Carbonyl group in C-ring and 5-OH in A-ring of genistein participated in zinc ion chelating as same as those in luteolin. In the case of insoflavones, 4-carbonyl and 5-OH chelated well to the metal ion, too.
20 B-ring of luteolin occupies two biding pockets, S1' and S2' and each hydroxyl groups form hydrogen bonds with ADAMTS-4 while B-ring of genistein just binds to near the zinc ion in ADAMTS-4 but it did not form any hydrogen bond interactions with ADAMTS-4. Therefore, we proposed that luteolin can bind to ADATMTS-4 stronger than genistein with these additional hydrogen bonding interactions. The docking energy and other scores showed that the binding model of luteolin and ADMATS-4 is more stable than the case of genistein (data not shown). The specific docking model of these two flavonoids and ADMAMTS-4 are shown in Figure 3 .
Through these docking process we confirmed that luteolin binds to ADAMTS-4 with two hydrogen bonding interactions and these strong binding could contribute to the remarkable inhibitory activity against ADMATS-4.
Conclusion
Luteolin is a remarkable inhibitor of ADAMTS-4 compared with genistein. In docking results, 4-carbonyl and 5-OH of luteolin chelated well to the zinc ion in active site and 3'-and 4'-OH of luteolin formed two hydrogen bonds with the side chain of D328 and backbone amide of M395, respectively. On the other hand, less active inhibitor, genistein did not formed hydrogen bonding interactions with ADAMTS-4. Therefore, luteolin binds to ADAMTS-4 tightly and these strong binding contribute to it high inhibitory activity against ADMATS-4.
